RxDoctor Payments Data

Michelle Groves, MD

Family Medicine · Cincinnati, OHNPI 1689801144

Payments from drug & device makers

$2,674in general payments, 2019–2025

Across 146 payments — averaging $18.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$639
  • Abbott$310
  • Novo Nordisk$200
  • GSK$187
  • Pfizer$128
  • Boehringer Ingelheim$125
  • plus $1K from 26 others

What the payments were for

  • Food & beverage$2,674100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,674 in reported general payments places this provider in the 75th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$68,971
Medicare patients
152
Services billed
857

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin33$50,850
EliquisApixaban50$46,043
OzempicSemaglutide26$45,251
MounjaroTirzepatide29$44,661
JanuviaSitagliptin Phosphate36$40,106
TrulicityDulaglutide33$36,473
FarxigaDapagliflozin Propanediol34$33,388
XareltoRivaroxaban20$22,677
Breo ElliptaFluticasone/Vilanterol30$15,906
Lantus SolostarInsulin Glargine,hum.Rec.Anlog51$8,783
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr12$8,403
Arnuity ElliptaFluticasone Furoate11$6,388
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog11$5,594
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen66$2,942
Albuterol Sulfate HfaAlbuterol Sulfate100$2,713

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$123$81,13462 claims
Boehringer IngelheimJardiance$125$50,85033 claims
PfizerEliquis$128$46,04350 claims
Novo NordiskOzempic$200$45,25126 claims
MerckJanuvia$88$40,10636 claims
AstraZenecaFarxiga$62$33,38834 claims
GSKBreo Ellipta, Anoro Ellipta, Arnuity Ellipta$187$30,69653 claims
Johnson & JohnsonXarelto$14$22,67720 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Cincinnati

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →